Wearable Continuous Glucose Monitor (CGM) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512242911

Publication Date:

December 5, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

A continuous glucose monitor (CGM) is a wearable device that tracks blood glucose (sugar) every few minutes, throughout the day and night. The readings are relayed in real time to a device which can be read by the patient, caregiver or health-care provider, even remotely.
The global market for Wearable Continuous Glucose Monitor (CGM) was estimated to be worth US$ 4025 million in 2023 and is forecast to a readjusted size of US$ 16130 million by 2030 with a CAGR of 21.6% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Wearable Continuous Glucose Monitor (CGM), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Wearable Continuous Glucose Monitor (CGM) by region & country, by Type, and by Application.
The Wearable Continuous Glucose Monitor (CGM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Continuous Glucose Monitor (CGM).
Market Segmentation
By Company
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
Segment by Type:
Type 1 Diabetes
Type 2 Diabetes
Segment by Application
Child
Adult
Elderly
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Wearable Continuous Glucose Monitor (CGM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Wearable Continuous Glucose Monitor (CGM) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Wearable Continuous Glucose Monitor (CGM) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Wearable Continuous Glucose Monitor (CGM) Product Introduction
1.2 Global Wearable Continuous Glucose Monitor (CGM) Market Size Forecast
1.2.1 Global Wearable Continuous Glucose Monitor (CGM) Sales Value (2019-2030)
1.2.2 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume (2019-2030)
1.2.3 Global Wearable Continuous Glucose Monitor (CGM) Sales Price (2019-2030)
1.3 Wearable Continuous Glucose Monitor (CGM) Market Trends & Drivers
1.3.1 Wearable Continuous Glucose Monitor (CGM) Industry Trends
1.3.2 Wearable Continuous Glucose Monitor (CGM) Market Drivers & Opportunity
1.3.3 Wearable Continuous Glucose Monitor (CGM) Market Challenges
1.3.4 Wearable Continuous Glucose Monitor (CGM) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Wearable Continuous Glucose Monitor (CGM) Players Revenue Ranking (2023)
2.2 Global Wearable Continuous Glucose Monitor (CGM) Revenue by Company (2019-2024)
2.3 Global Wearable Continuous Glucose Monitor (CGM) Players Sales Volume Ranking (2023)
2.4 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume by Company Players (2019-2024)
2.5 Global Wearable Continuous Glucose Monitor (CGM) Average Price by Company (2019-2024)
2.6 Key Manufacturers Wearable Continuous Glucose Monitor (CGM) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Wearable Continuous Glucose Monitor (CGM) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Wearable Continuous Glucose Monitor (CGM)
2.9 Wearable Continuous Glucose Monitor (CGM) Market Competitive Analysis
2.9.1 Wearable Continuous Glucose Monitor (CGM) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Wearable Continuous Glucose Monitor (CGM) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wearable Continuous Glucose Monitor (CGM) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Type 1 Diabetes
3.1.2 Type 2 Diabetes
3.2 Global Wearable Continuous Glucose Monitor (CGM) Sales Value by Type
3.2.1 Global Wearable Continuous Glucose Monitor (CGM) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Wearable Continuous Glucose Monitor (CGM) Sales Value, by Type (2019-2030)
3.2.3 Global Wearable Continuous Glucose Monitor (CGM) Sales Value, by Type (%) (2019-2030)
3.3 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume by Type
3.3.1 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume, by Type (2019-2030)
3.3.3 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume, by Type (%) (2019-2030)
3.4 Global Wearable Continuous Glucose Monitor (CGM) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Child
4.1.2 Adult
4.1.3 Elderly
4.2 Global Wearable Continuous Glucose Monitor (CGM) Sales Value by Application
4.2.1 Global Wearable Continuous Glucose Monitor (CGM) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Wearable Continuous Glucose Monitor (CGM) Sales Value, by Application (2019-2030)
4.2.3 Global Wearable Continuous Glucose Monitor (CGM) Sales Value, by Application (%) (2019-2030)
4.3 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume by Application
4.3.1 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume, by Application (2019-2030)
4.3.3 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume, by Application (%) (2019-2030)
4.4 Global Wearable Continuous Glucose Monitor (CGM) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Wearable Continuous Glucose Monitor (CGM) Sales Value by Region
5.1.1 Global Wearable Continuous Glucose Monitor (CGM) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Wearable Continuous Glucose Monitor (CGM) Sales Value by Region (2019-2024)
5.1.3 Global Wearable Continuous Glucose Monitor (CGM) Sales Value by Region (2025-2030)
5.1.4 Global Wearable Continuous Glucose Monitor (CGM) Sales Value by Region (%), (2019-2030)
5.2 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume by Region
5.2.1 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume by Region (2019-2024)
5.2.3 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume by Region (2025-2030)
5.2.4 Global Wearable Continuous Glucose Monitor (CGM) Sales Volume by Region (%), (2019-2030)
5.3 Global Wearable Continuous Glucose Monitor (CGM) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
5.4.2 North America Wearable Continuous Glucose Monitor (CGM) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
5.5.2 Europe Wearable Continuous Glucose Monitor (CGM) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
5.6.2 Asia Pacific Wearable Continuous Glucose Monitor (CGM) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
5.7.2 South America Wearable Continuous Glucose Monitor (CGM) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
5.8.2 Middle East & Africa Wearable Continuous Glucose Monitor (CGM) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Wearable Continuous Glucose Monitor (CGM) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Wearable Continuous Glucose Monitor (CGM) Sales Value
6.2.1 Key Countries/Regions Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Wearable Continuous Glucose Monitor (CGM) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
6.3.2 United States Wearable Continuous Glucose Monitor (CGM) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Wearable Continuous Glucose Monitor (CGM) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
6.4.2 Europe Wearable Continuous Glucose Monitor (CGM) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Wearable Continuous Glucose Monitor (CGM) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
6.5.2 China Wearable Continuous Glucose Monitor (CGM) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Wearable Continuous Glucose Monitor (CGM) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
6.6.2 Japan Wearable Continuous Glucose Monitor (CGM) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Wearable Continuous Glucose Monitor (CGM) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
6.7.2 South Korea Wearable Continuous Glucose Monitor (CGM) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Wearable Continuous Glucose Monitor (CGM) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
6.8.2 Southeast Asia Wearable Continuous Glucose Monitor (CGM) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Wearable Continuous Glucose Monitor (CGM) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Wearable Continuous Glucose Monitor (CGM) Sales Value, 2019-2030
6.9.2 India Wearable Continuous Glucose Monitor (CGM) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Wearable Continuous Glucose Monitor (CGM) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Dexcom
7.1.1 Dexcom Company Information
7.1.2 Dexcom Introduction and Business Overview
7.1.3 Dexcom Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Dexcom Wearable Continuous Glucose Monitor (CGM) Product Offerings
7.1.5 Dexcom Recent Development
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Information
7.2.2 Abbott Laboratories Introduction and Business Overview
7.2.3 Abbott Laboratories Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Laboratories Wearable Continuous Glucose Monitor (CGM) Product Offerings
7.2.5 Abbott Laboratories Recent Development
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Introduction and Business Overview
7.3.3 Medtronic Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Medtronic Wearable Continuous Glucose Monitor (CGM) Product Offerings
7.3.5 Medtronic Recent Development
7.4 Senseonics Holdings
7.4.1 Senseonics Holdings Company Information
7.4.2 Senseonics Holdings Introduction and Business Overview
7.4.3 Senseonics Holdings Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Senseonics Holdings Wearable Continuous Glucose Monitor (CGM) Product Offerings
7.4.5 Senseonics Holdings Recent Development
7.5 GlySens Incorporated
7.5.1 GlySens Incorporated Company Information
7.5.2 GlySens Incorporated Introduction and Business Overview
7.5.3 GlySens Incorporated Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 GlySens Incorporated Wearable Continuous Glucose Monitor (CGM) Product Offerings
7.5.5 GlySens Incorporated Recent Development
7.6 Meiqi Medical Equipment
7.6.1 Meiqi Medical Equipment Company Information
7.6.2 Meiqi Medical Equipment Introduction and Business Overview
7.6.3 Meiqi Medical Equipment Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Meiqi Medical Equipment Wearable Continuous Glucose Monitor (CGM) Product Offerings
7.6.5 Meiqi Medical Equipment Recent Development
7.7 San Meditech
7.7.1 San Meditech Company Information
7.7.2 San Meditech Introduction and Business Overview
7.7.3 San Meditech Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 San Meditech Wearable Continuous Glucose Monitor (CGM) Product Offerings
7.7.5 San Meditech Recent Development
8 Industry Chain Analysis
8.1 Wearable Continuous Glucose Monitor (CGM) Industrial Chain
8.2 Wearable Continuous Glucose Monitor (CGM) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Wearable Continuous Glucose Monitor (CGM) Sales Model
8.5.2 Sales Channel
8.5.3 Wearable Continuous Glucose Monitor (CGM) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂